Show simple item record

dc.contributor.authorXia, Xugang
dc.contributor.authorZhou, Hongxia
dc.contributor.authorSamper, Enrique
dc.contributor.authorMelov, Simon
dc.contributor.authorXu, Zuoshang
dc.date2022-08-11T08:09:36.000
dc.date.accessioned2022-08-23T16:36:58Z
dc.date.available2022-08-23T16:36:58Z
dc.date.issued2006-02-02
dc.date.submitted2009-04-02
dc.identifier.citationPLoS Genet. 2006 Jan;2(1):e10. Epub 2006 Jan 27. <a href="http://dx.doi.org/10.1371/journal.pgen.0020010">Link to article on publisher's site</a>
dc.identifier.issn1553-7404 (Electronic)
dc.identifier.doi10.1371/journal.pgen.0020010
dc.identifier.pmid16450009
dc.identifier.urihttp://hdl.handle.net/20.500.14038/38907
dc.description.abstractRNA interference (RNAi) has been used increasingly for reverse genetics in invertebrates and mammalian cells, and has the potential to become an alternative to gene knockout technology in mammals. Thus far, only RNA polymerase III (Pol III)-expressed short hairpin RNA (shRNA) has been used to make shRNA-expressing transgenic mice. However, widespread knockdown and induction of phenotypes of gene knockout in postnatal mice have not been demonstrated. Previous studies have shown that Pol II synthesizes micro RNAs (miRNAs)-the endogenous shRNAs that carry out gene silencing function. To achieve efficient gene knockdown in mammals and to generate phenotypes of gene knockout, we designed a construct in which a Pol II (ubiquitin C) promoter drove the expression of an shRNA with a structure that mimics human miRNA miR-30a. Two transgenic lines showed widespread and sustained shRNA expression, and efficient knockdown of the target gene Sod2. These mice were viable but with phenotypes of SOD2 deficiency. Bigenic heterozygous mice generated by crossing these two lines showed nearly undetectable target gene expression and phenotypes consistent with the target gene knockout, including slow growth, fatty liver, dilated cardiomyopathy, and premature death. This approach opens the door of RNAi to a wide array of well-established Pol II transgenic strategies and offers a technically simpler, cheaper, and quicker alternative to gene knockout by homologous recombination for reverse genetics in mice and other mammalian species.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=16450009&dopt=Abstract">Link to Article in PubMed</a>
dc.subject3' Untranslated Regions
dc.subjectAnimals
dc.subjectBase Sequence
dc.subjectDNA Primers
dc.subjectFemale
dc.subjectFertilization
dc.subjectGene Expression Regulation, Enzymologic
dc.subjectMice
dc.subjectMice, Knockout
dc.subjectMice, Transgenic
dc.subjectNucleic Acid Conformation
dc.subjectOvum
dc.subjectPhenotype
dc.subjectPolymerase Chain Reaction
dc.subjectRNA
dc.subjectRNA Interference
dc.subjectRNA Polymerase II
dc.subjectSuperoxide Dismutase
dc.subjectLife Sciences
dc.subjectMedicine and Health Sciences
dc.titlePol II-expressed shRNA knocks down Sod2 gene expression and causes phenotypes of the gene knockout in mice
dc.typeJournal Article
dc.source.journaltitlePLoS genetics
dc.source.volume2
dc.source.issue1
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=2739&amp;context=oapubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/1740
dc.identifier.contextkey808505
refterms.dateFOA2022-08-23T16:36:58Z
html.description.abstract<p>RNA interference (RNAi) has been used increasingly for reverse genetics in invertebrates and mammalian cells, and has the potential to become an alternative to gene knockout technology in mammals. Thus far, only RNA polymerase III (Pol III)-expressed short hairpin RNA (shRNA) has been used to make shRNA-expressing transgenic mice. However, widespread knockdown and induction of phenotypes of gene knockout in postnatal mice have not been demonstrated. Previous studies have shown that Pol II synthesizes micro RNAs (miRNAs)-the endogenous shRNAs that carry out gene silencing function. To achieve efficient gene knockdown in mammals and to generate phenotypes of gene knockout, we designed a construct in which a Pol II (ubiquitin C) promoter drove the expression of an shRNA with a structure that mimics human miRNA miR-30a. Two transgenic lines showed widespread and sustained shRNA expression, and efficient knockdown of the target gene Sod2. These mice were viable but with phenotypes of SOD2 deficiency. Bigenic heterozygous mice generated by crossing these two lines showed nearly undetectable target gene expression and phenotypes consistent with the target gene knockout, including slow growth, fatty liver, dilated cardiomyopathy, and premature death. This approach opens the door of RNAi to a wide array of well-established Pol II transgenic strategies and offers a technically simpler, cheaper, and quicker alternative to gene knockout by homologous recombination for reverse genetics in mice and other mammalian species.</p>
dc.identifier.submissionpathoapubs/1740
dc.contributor.departmentDepartment of Biochemistry and Molecular Pharmacology
dc.source.pagese10


Files in this item

Thumbnail
Name:
16450009.pdf
Size:
376.3Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record